These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29141530)

  • 1. Recent Advances and Challenges in Steroid Metabolomics for Biomarker Discovery.
    Kotłowska A; Szefer P
    Curr Med Chem; 2019; 26(1):29-45. PubMed ID: 29141530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations.
    Jeanneret F; Tonoli D; Rossier MF; Saugy M; Boccard J; Rudaz S
    J Chromatogr A; 2016 Jan; 1430():97-112. PubMed ID: 26195035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics analysis for biomarker discovery: advances and challenges.
    Monteiro MS; Carvalho M; Bastos ML; Guedes de Pinho P
    Curr Med Chem; 2013; 20(2):257-71. PubMed ID: 23210853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for the Assessment of Metabolic Profiles of Steroid Hormones in View of Diagnostics and Drug Monitoring: Analytical Problems and Challenges.
    Plenis A; Oledzka I; Kowalski P; Baczek T
    Curr Drug Metab; 2016; 17(7):703-20. PubMed ID: 27138598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges.
    Burton C; Ma Y
    Curr Med Chem; 2019; 26(1):5-28. PubMed ID: 28914192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based metabolic signatures of sex steroids in breast cancer.
    Choi MH
    Mol Cell Endocrinol; 2018 May; 466():81-85. PubMed ID: 28928086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for modulatory effects on steroidogenesis using the human H295R adrenocortical cell line: a metabolomics approach.
    Rijk JC; Peijnenburg AA; Blokland MH; Lommen A; Hoogenboom RL; Bovee TF
    Chem Res Toxicol; 2012 Aug; 25(8):1720-31. PubMed ID: 22768806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The art of measuring steroids: Principles and practice of current hormonal steroid analysis.
    Wudy SA; Schuler G; Sánchez-Guijo A; Hartmann MF
    J Steroid Biochem Mol Biol; 2018 May; 179():88-103. PubMed ID: 28962971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel strategies for clinical investigation and biomarker discovery: a guide to applied metabolomics.
    Carneiro G; Radcenco AL; Evaristo J; Monnerat G
    Horm Mol Biol Clin Investig; 2019 Jan; 38(3):. PubMed ID: 30653466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Metabolomics Approach To Detect the Misuse of Steroidal Aromatase Inhibitors in Equine Sports by Biomarker Profiling.
    Chan GH; Ho EN; Leung DK; Wong KS; Wan TS
    Anal Chem; 2016 Jan; 88(1):764-72. PubMed ID: 26632865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in lipidomics: Analytical and clinical perspectives.
    Sethi S; Brietzke E
    Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():8-16. PubMed ID: 28039059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bringing GC-MS profiling of steroids into clinical applications.
    Choi MH; Chung BC
    Mass Spectrom Rev; 2015; 34(2):219-36. PubMed ID: 24965919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
    Zhang A; Sun H; Yan G; Wang P; Wang X
    Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomics and Biomarker Discovery in Kidney Disease.
    Afshinnia F; Rajendiran TM; Wernisch S; Soni T; Jadoon A; Karnovsky A; Michailidis G; Pennathur S
    Semin Nephrol; 2018 Mar; 38(2):127-141. PubMed ID: 29602396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra performance liquid chromatography-tandem mass spectrometry method for profiling of steroid metabolome in human tissue.
    Gaikwad NW
    Anal Chem; 2013 May; 85(10):4951-60. PubMed ID: 23597399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the analytical methodologies: Profiling steroids in familiar pathways-challenging dogmas.
    Bloem LM; Storbeck KH; Swart P; du Toit T; Schloms L; Swart AC
    J Steroid Biochem Mol Biol; 2015 Sep; 153():80-92. PubMed ID: 25869556
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.